Modelling Disease Progression in Alzheimer's Disease: A Review of Modelling Methods used for Cost-Effectiveness Analysis

Author： Green Colin  

Publisher： Adis International

ISSN： 1170-7690

Source： PharmacoEconomics, Vol.25, Iss.9, 2007-01, pp. : 735-750

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Health Utilities in Alzheimer’s Disease and Implications for Cost-Effectiveness Analysis

By Neumann Peter J.  

PharmacoEconomics, Vol. 23, Iss. 6, 2005-01 ,pp. : 537-541

Adis International

Access to resources Recommend Favorite

An Outline For a Cost-Effectiveness Analysis of a Drug For Patients With Alzheimer's Disease

By Busschbach J.J.V.  

PharmacoEconomics, Vol. 13, Iss. 1 Part 2, 1998-01 ,pp. : 21-34

Adis International

Access to resources Recommend Favorite

Modelling the Cost Effectiveness of Treatments for Parkinson's Disease: A Methodological Review

By Dams Judith  

PharmacoEconomics, Vol. 29, Iss. 12, 2011-12 ,pp. : 1025-1049

Adis International

Access to resources Recommend Favorite

Modelling the Cost Effectiveness of Cholinesterase Inhibitors in the Management of Mild to Moderately Severe Alzheimer's Disease

By Green Colin   Picot Joanna   Loveman Emma   Takeda Andrea   Kirby Jo   Clegg Andrew  

PharmacoEconomics, Vol. 23, Iss. 12, 2005-01 ,pp. : 1271-1282

Adis International

Access to resources Recommend Favorite

Modelling the Cost Effectiveness of Cholinesterase Inhibitors in the Management of Mild to Moderately Severe Alzheimer's Disease

By Bosanquet Nick  

PharmacoEconomics, Vol. 24, Iss. 6, 2006-01 ,pp. : 623-625

Adis International

Access to resources Recommend Favorite